Fmoc-(R)-3-amino-4-(2-thienyl)butyric acid is a non-proteinogenic amino acid derivative. Its structure features a thiophene ring, a chiral center with (R)-configuration, and an Fmoc (9-fluorenylmethoxycarbonyl) protecting group on the amine functionality. This compound is a specialized building block designed for solid-phase peptide synthesis (SPPS). The primary application of this compound is in the synthesis of peptides and peptidomimetics. The Fmoc group is a standard protecting group in Fmoc-based SPPS, allowing for orthogonal deprotection under mild basic conditions. The incorporation of the thiophene moiety can impart unique conformational, electronic, or hydrophobic properties to the resulting peptide, which is valuable in medicinal chemistry for modulating bioactivity, stability, or receptor binding affinity. It is used in research to develop novel therapeutic peptides. As a chiral, heterocyclic amino acid derivative, it serves as a key intermediate for constructing complex peptide-based drug candidates, particularly those targeting specific protein-protein interactions or requiring enhanced metabolic stability. Its use is confined to research and development laboratories.